MCR 313 (Lamivudine 150 mg)
Pill with imprint MCR 313 is White, Four-sided and has been identified as Lamivudine 150 mg. It is supplied by Appco Pharma LLC.
Lamivudine is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MCR 313
Lamivudine
- Imprint
- MCR 313
- Strength
- 150 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Appco Pharma LLC
- National Drug Code (NDC)
- 55801-0313
- Inactive Ingredients
-
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
polysorbate 80,
sodium starch glycolate type A potato,
titanium dioxide
Note: Inactive ingredients may vary.
More about lamivudine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (5)
- Drug images
- Pricing & coupons
- En español
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Patient resources
- Other brands
- Epivir, Epivir-HBV
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.